Comparison of Predicted Probabilities of Proportional Hazards Regression and Linear Discriminant Analysis Methods Using a Colorectal Cancer Molecular Biomarker Database
暂无分享,去创建一个
J. Hardin | U. Manne | W. Grizzle | N. Jhala | A. Bartolucci | S. Meleth | V. Katkoori | C. Chatla | Billie Anderson
[1] W. Grizzle,et al. Novel approaches to smoothing and comparing SELDI TOF spectra , 2007, Cancer Informatics.
[2] H. Burke,et al. Outcome prediction and the future of the TNM staging system. , 2004, Journal of the National Cancer Institute.
[3] D. Ransohoff. Rules of evidence for cancer molecular-marker discovery and validation , 2004, Nature Reviews Cancer.
[4] H. Weiss,et al. Prognostic Significance of p27kip-1 Expression in Colorectal Adenocarcinomas Is Associated with Tumor Stage , 2004, Clinical Cancer Research.
[5] B. Gary,et al. Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] H. Weiss,et al. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] U. Manne,et al. Bcl‐2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas , 2000, International journal of cancer.
[8] M E Hammond,et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.
[9] U. Manne,et al. Nuclear accumulation of p53 in colorectal adenocarcinoma , 1998, Cancer.
[10] R. Poczatek,et al. Prognostic significance of Bcl‐2 expression and p53 nuclear accumulation in colorectal adenocarcinoma , 1997, International journal of cancer.
[11] R. Tibshirani,et al. Statistical Applications in Genetics and Molecular Biology Pre-validation and inference in microarrays , 2011 .
[12] U. Manne,et al. Immunohistochemical Evaluation of Biomarkers in Prostatic and Colorectal Neoplasia , 1998 .
[13] S. Hamilton,et al. Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms. , 1996, The Journal of pathology.
[14] R J Salmon,et al. [Prognostic factors of colorectal cancer]. , 1989, Pathologie-biologie.